skip to Main Content
  • This page as PDF

Maximize Exchange Opportunities for Life Sciences


As states establish health insurance exchanges, insurers are making benefit design and formulary decisions that will impact product coverage. Pharmaceutical and device manufacturers face opportunities to reach approximately 25 million new patients, but federal rules will present patient access challenges. Join Avalere experts and learn how to navigate this new contracting environment.

During this webinar, you will:

Identify key milestones for plans’ exchange participation in advance of open enrollment in October 2013
Understand projected enrollment and benefit designs for exchange plans and the impact on patient access to drugs and services
Assess opportunities and risks for your product portfolio based on expected cost-sharing structures, utilization management controls, and use of limited networks in exchange plans


Caroline Pearson formerly oversaw the firm’s content generation across consulting services, research products, and public visibility.
Back To Top